NSAV Holding Inc (NSAV)

[thomm]

found interesting; NSAV has contracted with Wilton Group which will help determine the basis of the purchase price for their 25% acquired stake. If the acquisition goes through it will be the third critical medical arrangement that the company has completed in the last eight months.

Through their Chinese based subsidiary Vital Strategic Research Institute the company engaged Eli Lilly which entails VSRI providing Cardio Vascular Disease assessment of diabetic patients to Eli Lilly in China. After the Eli Lilly agreement, The President of NSAV indicated that they were looking to complete more deals and acquisitions to enhance NSAV’s shareholder value.